beta-casomorphin 7 has been researched along with glucagon in 2 studies
| Studies (beta-casomorphin 7) | Trials (beta-casomorphin 7) | Recent Studies (post-2010) (beta-casomorphin 7) | Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) |
|---|---|---|---|---|---|
| 90 | 3 | 36 | 26,039 | 1,498 | 3,054 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miao, J; Yin, H; Zhang, Y | 1 |
| Miao, J; Wang, S; Zhang, W; Zhang, Y | 1 |
2 other study(ies) available for beta-casomorphin 7 and glucagon
| Article | Year |
|---|---|
Protective effect of beta-casomorphin-7 on type 1 diabetes rats induced with streptozotocin.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Type 1; Endorphins; Glucagon; Glycogen; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Malondialdehyde; Oxidative Stress; Oxidoreductases; Peptide Fragments; Random Allocation; Rats; Rats, Sprague-Dawley; Streptozocin; Time Factors; Weight Gain | 2010 |
The protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endorphins; Epithelial Cells; Glucagon; Glutathione Peroxidase; Hydrogen Peroxide; Insulin; Isoenzymes; Kidney; Losartan; Male; Malondialdehyde; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2013 |